Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018 By Admin on November 21, 2018 GSK retains No 1 position, as Novartis overtakes J&J to take 2nd place. Takeda jumps 10 places to 5th. Original source: https://health.economictimes.indiatimes.com/news/pharma/only-a-handful-of-pharma-cos-are-developing-the-much-needed-medicines-for-the-poor-atmi-2018/66711514?utm_source=RSS&utm_medium=ETRSS Also Read: Biocon Biologics appoints M.B. Chinappa as CFO Published in Industry News Health NewsPharma ArticlesPharma News Admin More from Industry NewsMore posts in Industry News »Zydus cuts price of generic remdesivirFrench pharma firm guilty of fraud, manslaughter over weight loss pill: courtEquity indices swing higher, metal and pharma stocks gainFrench pharma giant faces verdict on weight loss pill deaths